Description
The Food and Drug Administration (FDA) invites you to participate in a stakeholder teleconference and Twitter Chat regarding mobile medical applications. The stakeholder teleconference will be held Tuesday, July 19, 2011 at 12:00 noon ET , and consist of a brief presentation by Bakul Patel, MSEE, MBA, Policy Advisor, Center for Devices and Radiological Health, FDA, followed by a question and answer session. The moderator for the teleconference will be Lawrence Bachorik, Assistant Commissioner, Office of External Relations, Office of External Affairs, FDA. Stakeholders may participate by dialing 888-810-4794 or for international stakeholders, 1-212-287-1829. The passcode for all callers is "FDA1." A replay of the briefing will be available about one hour after the call ends until July 26, 2011, by calling 888-568-0616, or for international callers, 1-402-998-1519. We also invite you to participate in a Twitter Chat with FDA on mobile medical applications on Tuesday, July 19, at 3:00 PM ET . You do not need a Twitter account to view the chat; however, if you would like to participate in the chat (i.e., ask questions, respond to questions, etc.), you will need to have a Twitter account. How to Monitor the Chat without a Twitter Account : If you would like to monitor the Twitter chat and you do not wish to create a Twitter account, simply go to www.search.twitter.com. Type in the search engine "#FDAApps" and press enter. You will get a live feed of all of the questions and responses that include the hashtag "#FDAApps". How to Set Up a Twitter Account : 1. Go to www.twitter.com 2. Click on the link that says "Sign Up" 3. Follow the instructions to create a Twitter account Participate in the Twitter Chat with FDA : FDA will be tweeting with the hashtag "#FDAApps." Every tweet that FDA will publish and respond to will have to have #FDAApps somewhere in the tweet (either beginning or end) in order for us to see it and respond to it accordingly. FDA Twitter Account (that will be used for Twitter Chat): @FDADeviceInfo Thank you for your interest in FDA. We look forward to your participation in the stakeholder call and Twitter Chat.